PROGRAM CHAIR
Michael Wechsler, MD, MMSc
Director, The Cohen Family Asthma Institute
Professor of Medicine
National Jewish Health
Denver, Colorado
PROGRAM OVERVIEW
Severe asthma is a chronic and burdensome disease that can be difficult to manage optimally. Numerous biologic therapies are available to treat severe asthma, particularly for individuals with T2-high asthma, in which the inflammatory cytokine IL-5 drives elevated eosinophil levels. This enduring program is designed to help practitioners develop patient-centered strategies to diagnose and treat severe, eosinophilic asthma through case discussions and a review of guideline recommendations, clinical data, and best practices.
TARGET AUDIENCE
This activity is designed to meet the educational needs of pulmonologists, allergists, and associated advanced practice providers (APPs, eg, nurse practitioners, physician associates) involved in the management of patients with severe eosinophilic asthma.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the pathophysiology of T2 inflammation in severe asthma, including the role of IL-5 and eosinophils
- Create a plan for accurate assessment, diagnosis, and differentiation of related comorbidities when a patient presents with symptoms of severe asthma
- Assess data supporting current and emerging treatment options targeting T2 inflammation in severe asthma
- Incorporate equitable, patient-centered, and collaborative strategies in individualized severe asthma treatment plans
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until June 5, 2027. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER – US LEARNERS ONLY
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Relationships | Disclosures |
| Michael Wechsler, MD, MMSc |
Consultant | AbbVie, Allakos, Apogee Therapeutics, Areteia Therapeutics, Arrowhead, Avalo Therapeutics, Belenos Biosciences, Celldex Therapeutics, Connect Biopharma, Eli Lilly, Enveda Therapeutics, Equillium, General Medicines, Gilead Sciences, Jasper Therapeutics, Kinaset Therapeutics, Kymera Therapeutics, Merck, myBiometry, Pfizer, Pharming Group, Phylaxis Biosciences, Pulmatrix, RAPT Therapeutics, Recludix Pharma, Roche/Genentech, Sentien Biotechnologies, Sound Biologics, Tetherex, Uniquity Bio, Verona Pharma, Zura Bio, AstraZeneca, Amgen, Regeneron, GSK, Sanofi/Genzyme, Upstream Bio |
| Speakers Bureaus | AstraZeneca, Amgen, Regeneron, GSK, Sanofi | |
| Contracted research | AstraZeneca, Amgen, Regeneron, GSK, Sanofi/Genzyme | |
| Ownership Interest: Stocks | Upstream Bio, Cellergy Pharma |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Melissa Carter, Medical Director for Med Learning Group has nothing to disclose.
- Tom Bregartner, MBA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Nicolas Applyrs, DO, has nothing to disclose.
- Dominique Barton, B.S. BSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Associate Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: June 05, 2026
EXPIRATION DATE: June 05, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
